Email
Location
-
Proof of concept (2022) — TELOVACCINE: Targeting telomeric DNA damage response as a new strategy to fight immunosenescence and improve vaccine response
-
Proof of concept (2019) — FIREQUENCHER: Pharmacological inhibition of macrophage activation
-
Advanced (2018) — TeloRNAging: The role of damage-induced non coding RNA in the control of DNA damage response activation at telomeres in aging
-
Proof of concept (2016) — RNAging: The role of non coding RNA in organismal ageing
-
Proof of concept (2014) — DDRNA: DDRNA-based cancer therapy targeted telomeres
-
Advanced (2012) — DDRNA: A novel direct role of non coding RNA in DNA damage response activation

